Clinical Trial Update: Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) [Phase 2, Phase 3]

View source ↗

Summary

The FAVORIT trial evaluated folic acid–based B vitamin therapy for reducing vascular outcomes in kidney transplant recipients. The Phase 2/3 study is completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Chronic Kidney Disease

Drugs mentioned

• Vitamin B12 (cobalamin)
• Vitamin B6 (pyridoxine)
• folic acid (folic acid)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Chronic Kidney Disease, Cardiovascular Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-11-26